Your browser doesn't support javascript.
loading
Proteasome inhibition and mechanism of resistance to a synthetic, library-based hexapeptide.
Oerlemans, Ruud; Berkers, Celia R; Assaraf, Yehuda G; Scheffer, George L; Peters, Godefridus J; Verbrugge, Sue Ellen; Cloos, Jacqueline; Slootstra, Jerry; Meloen, Rob H; Shoemaker, Robert H; Dijkmans, Ben A C; Scheper, Rik J; Ovaa, Huib; Jansen, Gerrit.
Afiliação
  • Oerlemans R; Departments of Rheumatology, Amsterdam Rheumatology and Immunology Center, Cancer Center Amsterdam, Rm 2.46, VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
  • Berkers CR; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
  • Assaraf YG; The Fred Wyszkowski Cancer Research Laboratory, Faculty of Biology, Technion-Israel Institute of Technology, Haifa, Israel.
  • Scheffer GL; Department of Pathology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Peters GJ; Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Verbrugge SE; Departments of Rheumatology, Amsterdam Rheumatology and Immunology Center, Cancer Center Amsterdam, Rm 2.46, VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
  • Cloos J; Department of Pediatric Oncology/Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Slootstra J; Pepscan Therapeutics, Lelystad, The Netherlands.
  • Meloen RH; Pepscan Therapeutics, Lelystad, The Netherlands.
  • Shoemaker RH; Chemopreventive Agent Development Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Dijkmans BAC; Departments of Rheumatology, Amsterdam Rheumatology and Immunology Center, Cancer Center Amsterdam, Rm 2.46, VU University Medical Center, De Boelelaan 1117, 1081, HV, Amsterdam, The Netherlands.
  • Scheper RJ; Department of Pathology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Ovaa H; Division of Cell Biology II, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Jansen G; Department of Chemical Immunology, Leiden University Medical Center, Leiden, The Netherlands.
Invest New Drugs ; 36(5): 797-809, 2018 10.
Article em En | MEDLINE | ID: mdl-29442210
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Inibidores de Proteassoma / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oligopeptídeos / Inibidores de Proteassoma / Antineoplásicos Idioma: En Ano de publicação: 2018 Tipo de documento: Article